{"schema_version":"1","generated_at":"2026-11-03T22:35:46.160Z","data_as_of":null,"url":"https://www.findmykol.com/kol/ana-garrido-castro","json_url":"https://www.findmykol.com/kol/ana-garrido-castro/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"ana-garrido-castro","name":"Ana Garrido-Castro","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Broad Institute","institution_url":"https://www.findmykol.com/institution/broad-institute","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1386185874","orcid":"0000-0002-5989-6636","openalex":"A5024995771"},"summary":"Ana Garrido-Castro is an Oncology physician affiliated with Broad Institute. OpenAlex indexes 130 publications with 4,841 citations (h-index 25); ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":130,"cited_by_count":4841,"h_index":25,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":17,"shown":3,"withheld":14,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":20435.67,"payment_count":15,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386185874"},{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":12058.5,"payment_count":13,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386185874"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":10441.87,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386185874"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1386185874","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer","year":2026,"journal":"npj Precision Oncology","source_url":"https://doi.org/10.1038/s41698-026-01365-6","status":"verified"},{"title":"Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer","year":2025,"journal":"Journal for ImmunoTherapy of Cancer","source_url":"https://doi.org/10.1136/jitc-2024-010430","status":"verified"},{"title":"A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.511","status":"verified"},{"title":"Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing","year":2025,"journal":"Current Oncology Reports","source_url":"https://doi.org/10.1007/s11912-024-01628-0","status":"verified"},{"title":"Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer","year":2025,"journal":"ESMO Open","source_url":"https://doi.org/10.1016/j.esmoop.2025.105828","status":"verified"}],"source":"works"},"contact":{"address_1":"450 BROOKLINE AVE","city":"Boston","state":"MA","zip":"022155418","phone":"617-632-3000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1386185874","source":"identity"},"similar":[{"name":"Alan Mullen","slug":"alan-mullen","institution":"Broad Institute","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/alan-mullen","json_url":"https://www.findmykol.com/kol/alan-mullen/profile.json"},{"name":"Benjamin Ebert","slug":"benjamin-ebert","institution":"Broad Institute","specialty":"Hematology","url":"https://www.findmykol.com/kol/benjamin-ebert","json_url":"https://www.findmykol.com/kol/benjamin-ebert/profile.json"},{"name":"Susan Redline","slug":"susan-redline","institution":"Broad Institute","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/susan-redline","json_url":"https://www.findmykol.com/kol/susan-redline/profile.json"},{"name":"Patrick Ellinor","slug":"patrick-ellinor","institution":"Broad Institute","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/patrick-ellinor","json_url":"https://www.findmykol.com/kol/patrick-ellinor/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":14,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-06-02","provider_certified":"2021-06-02","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}